5AM Ventures

5AM Ventures

$24,000,000 Venture capital (Series G)
GeekWire

Seattle startup RareCyte raises $24M to advance new high-speed cell imaging platform

GeekWire , MedCity News

Impel NeuroPharma, fresh off IPO, gets FDA approval for nasal spray that treats migraines

MedCity News

Second FDA clinical hold for Aprea cancer drug cites safety data in another study

MedCity News

Pfizer commits $1B to Arvinas for share of protein degrading breast cancer drug

$80,000,000 IPO
GeekWire

Impel Neuropharma raises $80M in Washington state’s first IPO of 2021

neurons.AI

Pear Therapeutics Expands Platform with Digital Biomarkers, Machine Learning Algorithms and …

neurons.AI

Pear Therapeutics Expands Platform with Digital Biomarkers, Machine Learning Algorithms and …

GeekWire

Seattle biotech firm Impel NeuroPharma files for $75M IPO

Pulse 2.0

Cidara Therapeutics Stock Price Increased Over 5% Pre-Market: Why It Happened

Pulse 2.0

Arvinas Stock Price Doubled Today: Why It Happened

$80,000,000 Venture capital (Series D)
MedCity News , Pulse 2.0

Pear Therapeutics raises $80M in push for reimbursement

$40,000,000 Venture capital (Series A)
WSJ Venture Capital

Kinaset Therapeutics Launches With $40 Million Series A to Advance Asthma Drug

$14,000,000 Venture capital (Series B)
3D Printing Industry , TCT Magazine

LightForce Orthodontics raises $14M in latest round of Series B funding

Pulse 2.0

Viveve Medical Stock (VIVE) Stock: Should I Buy It Now?

$78,000,000 Venture capital (Series A)
Pulse 2.0

Allogeneic Natural Killer Cell Therapy Company Artiva Biotherapeutics Raises $78 Million

Xconomy

Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic

Xconomy

NodThera Adds $55M to Advance Drugs to Better Regulate Inflammation

$55,000,000 Venture capital (Series B)
WSJ Venture Capital

Biotech Startup NodThera to Combat Inflammation With $55 Million Series B

$105,000,000 Venture capital (Series B)
FinSMEs

Akouos Raises $105M in Series B Financing

$105,000,000 Venture capital (Series B)
Pulse 2.0

Precision Genetic Medicine Company Akouos Secures $105 Million In Funding